nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—muscle cancer—sarcoma	0.197	0.375	CtDrD
Vincristine—kidney cancer—sarcoma	0.165	0.314	CtDrD
Vincristine—peripheral nervous system neoplasm—sarcoma	0.163	0.311	CtDrD
Vincristine—RALBP1—Doxorubicin—sarcoma	0.0632	0.182	CbGbCtD
Vincristine—ABCC10—Etoposide—sarcoma	0.034	0.0981	CbGbCtD
Vincristine—ABCC1—Dactinomycin—sarcoma	0.0233	0.0671	CbGbCtD
Vincristine—ABCC10—Doxorubicin—sarcoma	0.0232	0.0669	CbGbCtD
Vincristine—ABCC3—Etoposide—sarcoma	0.0214	0.0617	CbGbCtD
Vincristine—ABCC1—Mitoxantrone—sarcoma	0.0208	0.06	CbGbCtD
Vincristine—ABCC1—Epirubicin—sarcoma	0.0169	0.0486	CbGbCtD
Vincristine—ABCG2—Dactinomycin—sarcoma	0.0156	0.0449	CbGbCtD
Vincristine—ABCC3—Doxorubicin—sarcoma	0.0146	0.0421	CbGbCtD
Vincristine—ABCG2—Mitoxantrone—sarcoma	0.0139	0.0402	CbGbCtD
Vincristine—ABCC1—Etoposide—sarcoma	0.0131	0.0379	CbGbCtD
Vincristine—ABCB11—Doxorubicin—sarcoma	0.0126	0.0364	CbGbCtD
Vincristine—ABCC2—Etoposide—sarcoma	0.00972	0.028	CbGbCtD
Vincristine—ABCC1—Doxorubicin—sarcoma	0.00896	0.0258	CbGbCtD
Vincristine—ABCG2—Etoposide—sarcoma	0.00879	0.0253	CbGbCtD
Vincristine—CYP3A4—Thiotepa—sarcoma	0.007	0.0202	CbGbCtD
Vincristine—ABCC2—Doxorubicin—sarcoma	0.00663	0.0191	CbGbCtD
Vincristine—ABCG2—Doxorubicin—sarcoma	0.00599	0.0173	CbGbCtD
Vincristine—ABCB1—Dactinomycin—sarcoma	0.00561	0.0162	CbGbCtD
Vincristine—ABCB1—Mitoxantrone—sarcoma	0.00502	0.0145	CbGbCtD
Vincristine—CYP3A5—Etoposide—sarcoma	0.00487	0.014	CbGbCtD
Vincristine—ABCB1—Etoposide—sarcoma	0.00317	0.00914	CbGbCtD
Vincristine—CYP3A4—Mitoxantrone—sarcoma	0.00301	0.00868	CbGbCtD
Vincristine—ABCB1—Doxorubicin—sarcoma	0.00216	0.00623	CbGbCtD
Vincristine—NR0B1—Validated nuclear estrogen receptor beta network—SMARCB1—sarcoma	0.00206	0.108	CbGpPWpGaD
Vincristine—CYP3A4—Etoposide—sarcoma	0.0019	0.00547	CbGbCtD
Vincristine—Vinblastine—JUN—sarcoma	0.00174	1	CrCbGaD
Vincristine—CYP3A4—Doxorubicin—sarcoma	0.00129	0.00373	CbGbCtD
Vincristine—TUBB8—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000845	0.0444	CbGpPWpGaD
Vincristine—TUBA4A—mammary gland—sarcoma	0.000735	0.0182	CbGeAlD
Vincristine—RALBP1—Regulation of CDC42 activity—PLCG1—sarcoma	0.000673	0.0354	CbGpPWpGaD
Vincristine—TUBB3—hematopoietic system—sarcoma	0.00059	0.0146	CbGeAlD
Vincristine—NR0B1—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.00058	0.0305	CbGpPWpGaD
Vincristine—TUBB1—hematopoietic system—sarcoma	0.000576	0.0143	CbGeAlD
Vincristine—TUBB3—connective tissue—sarcoma	0.000568	0.014	CbGeAlD
Vincristine—TUBB6—mammary gland—sarcoma	0.000528	0.0131	CbGeAlD
Vincristine—TUBA4A—myometrium—sarcoma	0.000521	0.0129	CbGeAlD
Vincristine—TUBA4A—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000498	0.0262	CbGpPWpGaD
Vincristine—RALBP1—myometrium—sarcoma	0.000491	0.0121	CbGeAlD
Vincristine—TUBB8—testis—sarcoma	0.000473	0.0117	CbGeAlD
Vincristine—TUBA4A—seminal vesicle—sarcoma	0.000471	0.0116	CbGeAlD
Vincristine—TUBB4B—mammary gland—sarcoma	0.000459	0.0114	CbGeAlD
Vincristine—TUBA4A—hematopoietic system—sarcoma	0.000448	0.0111	CbGeAlD
Vincristine—RALBP1—RalA downstream regulated genes—NRAS—sarcoma	0.000447	0.0235	CbGpPWpGaD
Vincristine—RALBP1—seminal vesicle—sarcoma	0.000444	0.011	CbGeAlD
Vincristine—NR0B1—testis—sarcoma	0.00044	0.0109	CbGeAlD
Vincristine—TUBA4A—connective tissue—sarcoma	0.000431	0.0107	CbGeAlD
Vincristine—TUBB2A—Signaling events mediated by HDAC Class III—MYOD1—sarcoma	0.000429	0.0225	CbGpPWpGaD
Vincristine—TUBB2B—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000427	0.0225	CbGpPWpGaD
Vincristine—TUBB6—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000427	0.0225	CbGpPWpGaD
Vincristine—TUBB—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000424	0.0223	CbGpPWpGaD
Vincristine—RALBP1—hematopoietic system—sarcoma	0.000422	0.0104	CbGeAlD
Vincristine—TUBB3—lymphoid tissue—sarcoma	0.000415	0.0103	CbGeAlD
Vincristine—TUBB3—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000413	0.0217	CbGpPWpGaD
Vincristine—TUBB2B—myometrium—sarcoma	0.000404	0.00998	CbGeAlD
Vincristine—TUBB4A—embryo—sarcoma	0.000402	0.00994	CbGeAlD
Vincristine—TUBB2A—Pathogenic Escherichia coli infection—EZR—sarcoma	0.0004	0.021	CbGpPWpGaD
Vincristine—TUBA4A—smooth muscle tissue—sarcoma	0.000394	0.00975	CbGeAlD
Vincristine—TUBB1—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000391	0.0205	CbGpPWpGaD
Vincristine—TUBA4A—skin of body—sarcoma	0.000389	0.00962	CbGeAlD
Vincristine—RALBP1—RalA downstream regulated genes—KRAS—sarcoma	0.000385	0.0202	CbGpPWpGaD
Vincristine—TUBB—myometrium—sarcoma	0.000382	0.00945	CbGeAlD
Vincristine—TUBB2A—myometrium—sarcoma	0.00038	0.0094	CbGeAlD
Vincristine—TUBB6—myometrium—sarcoma	0.000375	0.00927	CbGeAlD
Vincristine—RALBP1—smooth muscle tissue—sarcoma	0.000372	0.00919	CbGeAlD
Vincristine—TUBB1—bone marrow—sarcoma	0.00037	0.00914	CbGeAlD
Vincristine—TUBB2B—seminal vesicle—sarcoma	0.000365	0.00902	CbGeAlD
Vincristine—TUBB4A—hematopoietic system—sarcoma	0.000359	0.00887	CbGeAlD
Vincristine—TUBB4A—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000351	0.0184	CbGpPWpGaD
Vincristine—TUBB4A—connective tissue—sarcoma	0.000345	0.00854	CbGeAlD
Vincristine—TUBB—seminal vesicle—sarcoma	0.000345	0.00854	CbGeAlD
Vincristine—TUBB2A—seminal vesicle—sarcoma	0.000343	0.00849	CbGeAlD
Vincristine—TUBA4A—cardiac atrium—sarcoma	0.00034	0.0084	CbGeAlD
Vincristine—TUBB6—seminal vesicle—sarcoma	0.000339	0.00837	CbGeAlD
Vincristine—TUBA4A—uterus—sarcoma	0.000338	0.00836	CbGeAlD
Vincristine—TUBB2B—connective tissue—sarcoma	0.000334	0.00825	CbGeAlD
Vincristine—ABCC10—myometrium—sarcoma	0.000328	0.00812	CbGeAlD
Vincristine—RALBP1—RalA downstream regulated genes—HRAS—sarcoma	0.000327	0.0172	CbGpPWpGaD
Vincristine—TUBB2A—hematopoietic system—sarcoma	0.000326	0.00807	CbGeAlD
Vincristine—TUBB4B—myometrium—sarcoma	0.000326	0.00806	CbGeAlD
Vincristine—TUBB3—testis—sarcoma	0.000323	0.00799	CbGeAlD
Vincristine—TUBB6—hematopoietic system—sarcoma	0.000322	0.00796	CbGeAlD
Vincristine—TUBB4B—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000321	0.0169	CbGpPWpGaD
Vincristine—RALBP1—cardiac atrium—sarcoma	0.00032	0.00792	CbGeAlD
Vincristine—RALBP1—uterus—sarcoma	0.000319	0.00788	CbGeAlD
Vincristine—TUBB1—testis—sarcoma	0.000316	0.00781	CbGeAlD
Vincristine—TUBA4A—lymphoid tissue—sarcoma	0.000315	0.00779	CbGeAlD
Vincristine—TUBB2A—connective tissue—sarcoma	0.000314	0.00777	CbGeAlD
Vincristine—TUBB4B—embryo—sarcoma	0.000313	0.00775	CbGeAlD
Vincristine—TUBB4A—skin of body—sarcoma	0.000312	0.00771	CbGeAlD
Vincristine—ABCC10—seminal vesicle—sarcoma	0.000297	0.00733	CbGeAlD
Vincristine—TUBA4A—tendon—sarcoma	0.000296	0.00733	CbGeAlD
Vincristine—TUBB4B—seminal vesicle—sarcoma	0.000294	0.00728	CbGeAlD
Vincristine—TUBB—smooth muscle tissue—sarcoma	0.000289	0.00715	CbGeAlD
Vincristine—TUBB2A—smooth muscle tissue—sarcoma	0.000287	0.00711	CbGeAlD
Vincristine—TUBA4A—bone marrow—sarcoma	0.000287	0.0071	CbGeAlD
Vincristine—NR0B1—Regulation of Androgen receptor activity—FOXO1—sarcoma	0.000285	0.015	CbGpPWpGaD
Vincristine—TUBB2A—skin of body—sarcoma	0.000284	0.00702	CbGeAlD
Vincristine—TUBB6—smooth muscle tissue—sarcoma	0.000284	0.00701	CbGeAlD
Vincristine—ABCC3—hematopoietic system—sarcoma	0.000283	0.007	CbGeAlD
Vincristine—ABCC10—hematopoietic system—sarcoma	0.000282	0.00697	CbGeAlD
Vincristine—SLC22A3—myometrium—sarcoma	0.000281	0.00694	CbGeAlD
Vincristine—TUBB6—skin of body—sarcoma	0.00028	0.00692	CbGeAlD
Vincristine—TUBB4B—hematopoietic system—sarcoma	0.00028	0.00692	CbGeAlD
Vincristine—RALBP1—tendon—sarcoma	0.000279	0.0069	CbGeAlD
Vincristine—ABCC1—S1P1 pathway—PLCG1—sarcoma	0.000277	0.0145	CbGpPWpGaD
Vincristine—TUBB4A—uterus—sarcoma	0.000271	0.0067	CbGeAlD
Vincristine—TUBA4A—Platelet degranulation—VEGFC—sarcoma	0.000271	0.0142	CbGpPWpGaD
Vincristine—RALBP1—bone marrow—sarcoma	0.00027	0.00669	CbGeAlD
Vincristine—SLC22A3—embryo—sarcoma	0.00027	0.00668	CbGeAlD
Vincristine—TUBB4B—connective tissue—sarcoma	0.000269	0.00666	CbGeAlD
Vincristine—TUBB2B—cardiac atrium—sarcoma	0.000263	0.00651	CbGeAlD
Vincristine—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.000258	0.0136	CbGpPWpGaD
Vincristine—SLC22A3—seminal vesicle—sarcoma	0.000254	0.00627	CbGeAlD
Vincristine—TUBB4A—lymphoid tissue—sarcoma	0.000253	0.00624	CbGeAlD
Vincristine—TUBB—cardiac atrium—sarcoma	0.000249	0.00616	CbGeAlD
Vincristine—TUBB—uterus—sarcoma	0.000248	0.00613	CbGeAlD
Vincristine—TUBB2A—cardiac atrium—sarcoma	0.000248	0.00613	CbGeAlD
Vincristine—TUBB2A—uterus—sarcoma	0.000247	0.0061	CbGeAlD
Vincristine—TUBB4B—smooth muscle tissue—sarcoma	0.000246	0.00609	CbGeAlD
Vincristine—TUBA4A—testis—sarcoma	0.000245	0.00607	CbGeAlD
Vincristine—TUBB6—cardiac atrium—sarcoma	0.000244	0.00604	CbGeAlD
Vincristine—ABCB11—testis—sarcoma	0.000244	0.00603	CbGeAlD
Vincristine—TUBB4B—skin of body—sarcoma	0.000243	0.00602	CbGeAlD
Vincristine—TUBB6—uterus—sarcoma	0.000243	0.00601	CbGeAlD
Vincristine—SLC22A3—hematopoietic system—sarcoma	0.000241	0.00596	CbGeAlD
Vincristine—TUBB4A—tendon—sarcoma	0.000237	0.00587	CbGeAlD
Vincristine—ABCC1—myometrium—sarcoma	0.000232	0.00574	CbGeAlD
Vincristine—SLC22A3—connective tissue—sarcoma	0.000232	0.00574	CbGeAlD
Vincristine—TUBA4A—liver—sarcoma	0.000232	0.00573	CbGeAlD
Vincristine—RALBP1—testis—sarcoma	0.000231	0.00572	CbGeAlD
Vincristine—ABCB11—liver—sarcoma	0.000231	0.0057	CbGeAlD
Vincristine—TUBB2B—tendon—sarcoma	0.000229	0.00567	CbGeAlD
Vincristine—TUBB6—lymphoid tissue—sarcoma	0.000227	0.0056	CbGeAlD
Vincristine—CYP3A7—liver—sarcoma	0.000226	0.00558	CbGeAlD
Vincristine—RALBP1—liver—sarcoma	0.000219	0.0054	CbGeAlD
Vincristine—TUBB—tendon—sarcoma	0.000217	0.00537	CbGeAlD
Vincristine—TUBB2A—tendon—sarcoma	0.000216	0.00534	CbGeAlD
Vincristine—TUBB2A—Signaling events mediated by HDAC Class III—FOXO1—sarcoma	0.000215	0.0113	CbGpPWpGaD
Vincristine—ABCC10—cardiac atrium—sarcoma	0.000214	0.00529	CbGeAlD
Vincristine—TUBB6—tendon—sarcoma	0.000213	0.00527	CbGeAlD
Vincristine—ABCC10—uterus—sarcoma	0.000213	0.00526	CbGeAlD
Vincristine—TUBB4B—cardiac atrium—sarcoma	0.000212	0.00525	CbGeAlD
Vincristine—SLC22A3—smooth muscle tissue—sarcoma	0.000212	0.00525	CbGeAlD
Vincristine—TUBB4B—uterus—sarcoma	0.000211	0.00523	CbGeAlD
Vincristine—TUBB—bone marrow—sarcoma	0.00021	0.0052	CbGeAlD
Vincristine—ABCC1—seminal vesicle—sarcoma	0.00021	0.00519	CbGeAlD
Vincristine—TUBB2A—bone marrow—sarcoma	0.000209	0.00517	CbGeAlD
Vincristine—ABCC3—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000209	0.011	CbGpPWpGaD
Vincristine—TUBB6—bone marrow—sarcoma	0.000206	0.0051	CbGeAlD
Vincristine—ABCC10—lymphoid tissue—sarcoma	0.000198	0.00491	CbGeAlD
Vincristine—TUBB4B—lymphoid tissue—sarcoma	0.000197	0.00487	CbGeAlD
Vincristine—TUBB4A—testis—sarcoma	0.000197	0.00486	CbGeAlD
Vincristine—ABCC1—S1P1 pathway—PDGFRB—sarcoma	0.000196	0.0103	CbGpPWpGaD
Vincristine—ABCG2—myometrium—sarcoma	0.000192	0.00475	CbGeAlD
Vincristine—CYP3A7-CYP3A51P—liver—sarcoma	0.000192	0.00474	CbGeAlD
Vincristine—TUBB2B—testis—sarcoma	0.00019	0.0047	CbGeAlD
Vincristine—ABCC10—tendon—sarcoma	0.000187	0.00461	CbGeAlD
Vincristine—TUBB4A—liver—sarcoma	0.000186	0.0046	CbGeAlD
Vincristine—TUBB4B—tendon—sarcoma	0.000185	0.00458	CbGeAlD
Vincristine—ABCC10—bone marrow—sarcoma	0.000181	0.00447	CbGeAlD
Vincristine—TUBB—testis—sarcoma	0.00018	0.00445	CbGeAlD
Vincristine—TUBB4B—bone marrow—sarcoma	0.000179	0.00444	CbGeAlD
Vincristine—TUBB8—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	0.000179	0.00941	CbGpPWpGaD
Vincristine—TUBB2A—testis—sarcoma	0.000179	0.00442	CbGeAlD
Vincristine—TUBA4A—lymph node—sarcoma	0.000178	0.0044	CbGeAlD
Vincristine—TUBB6—testis—sarcoma	0.000176	0.00436	CbGeAlD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—PLCG1—sarcoma	0.000175	0.00918	CbGpPWpGaD
Vincristine—ABCG2—seminal vesicle—sarcoma	0.000174	0.00429	CbGeAlD
Vincristine—NR0B1—Regulation of Androgen receptor activity—MDM2—sarcoma	0.000171	0.00898	CbGpPWpGaD
Vincristine—TUBB—liver—sarcoma	0.00017	0.0042	CbGeAlD
Vincristine—TUBB2A—liver—sarcoma	0.000169	0.00418	CbGeAlD
Vincristine—RALBP1—lymph node—sarcoma	0.000168	0.00414	CbGeAlD
Vincristine—TUBB6—liver—sarcoma	0.000167	0.00412	CbGeAlD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—ATF1—sarcoma	0.000166	0.00872	CbGpPWpGaD
Vincristine—ABCC3—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000165	0.00868	CbGpPWpGaD
Vincristine—ABCC1—S1P1 pathway—KDR—sarcoma	0.000162	0.00853	CbGpPWpGaD
Vincristine—ABCG2—HIF-2-alpha transcription factor network—FLT1—sarcoma	0.000156	0.00817	CbGpPWpGaD
Vincristine—ABCC3—testis—sarcoma	0.000155	0.00384	CbGeAlD
Vincristine—ABCC10—testis—sarcoma	0.000154	0.00382	CbGeAlD
Vincristine—TUBB4B—testis—sarcoma	0.000153	0.00379	CbGeAlD
Vincristine—CYP3A5—hematopoietic system—sarcoma	0.000153	0.00379	CbGeAlD
Vincristine—ABCC1—cardiac atrium—sarcoma	0.000151	0.00374	CbGeAlD
Vincristine—ABCC1—uterus—sarcoma	0.000151	0.00372	CbGeAlD
Vincristine—ABCC2—tendon—sarcoma	0.00015	0.0037	CbGeAlD
Vincristine—NR0B1—Regulation of Androgen receptor activity—JUN—sarcoma	0.000149	0.00781	CbGpPWpGaD
Vincristine—ABCC3—liver—sarcoma	0.000147	0.00363	CbGeAlD
Vincristine—ABCC10—liver—sarcoma	0.000146	0.00361	CbGeAlD
Vincristine—TUBB4B—liver—sarcoma	0.000145	0.00358	CbGeAlD
Vincristine—ABCG2—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000144	0.00757	CbGpPWpGaD
Vincristine—TUBB4A—lymph node—sarcoma	0.000143	0.00352	CbGeAlD
Vincristine—Neuropathy peripheral—Etoposide—sarcoma	0.000138	0.00206	CcSEcCtD
Vincristine—TUBB2B—lymph node—sarcoma	0.000138	0.00341	CbGeAlD
Vincristine—Stomatitis—Etoposide—sarcoma	0.000137	0.00204	CcSEcCtD
Vincristine—Leukopenia—Thiotepa—sarcoma	0.000137	0.00204	CcSEcCtD
Vincristine—Bone pain—Doxorubicin—sarcoma	0.000136	0.00203	CcSEcCtD
Vincristine—Leukopenia—Dactinomycin—sarcoma	0.000136	0.00203	CcSEcCtD
Vincristine—Alopecia—Mitoxantrone—sarcoma	0.000134	0.002	CcSEcCtD
Vincristine—Gait disturbance—Doxorubicin—sarcoma	0.000134	0.00199	CcSEcCtD
Vincristine—NR0B1—Regulation of Androgen receptor activity—SRC—sarcoma	0.000133	0.007	CbGpPWpGaD
Vincristine—Blood uric acid increased—Doxorubicin—sarcoma	0.000133	0.00198	CcSEcCtD
Vincristine—Convulsion—Thiotepa—sarcoma	0.000133	0.00198	CcSEcCtD
Vincristine—Neuropathy—Epirubicin—sarcoma	0.000132	0.00197	CcSEcCtD
Vincristine—SLC22A3—testis—sarcoma	0.000132	0.00327	CbGeAlD
Vincristine—Hypertension—Thiotepa—sarcoma	0.000132	0.00197	CcSEcCtD
Vincristine—Musculoskeletal pain—Doxorubicin—sarcoma	0.000132	0.00197	CcSEcCtD
Vincristine—ABCC1—tendon—sarcoma	0.000132	0.00326	CbGeAlD
Vincristine—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000131	0.00688	CbGpPWpGaD
Vincristine—TUBB—lymph node—sarcoma	0.00013	0.00322	CbGeAlD
Vincristine—Myalgia—Thiotepa—sarcoma	0.00013	0.00194	CcSEcCtD
Vincristine—TUBB2A—lymph node—sarcoma	0.00013	0.00321	CbGeAlD
Vincristine—Myalgia—Dactinomycin—sarcoma	0.000129	0.00193	CcSEcCtD
Vincristine—Coma—Epirubicin—sarcoma	0.000129	0.00192	CcSEcCtD
Vincristine—NR0B1—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000128	0.00673	CbGpPWpGaD
Vincristine—TUBB6—lymph node—sarcoma	0.000128	0.00316	CbGeAlD
Vincristine—Back pain—Mitoxantrone—sarcoma	0.000128	0.00191	CcSEcCtD
Vincristine—NR0B1—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000128	0.00671	CbGpPWpGaD
Vincristine—Mouth ulceration—Epirubicin—sarcoma	0.000127	0.0019	CcSEcCtD
Vincristine—Hypoaesthesia—Etoposide—sarcoma	0.000126	0.00187	CcSEcCtD
Vincristine—SLC22A3—liver—sarcoma	0.000125	0.00309	CbGeAlD
Vincristine—Urinary tract disorder—Etoposide—sarcoma	0.000125	0.00186	CcSEcCtD
Vincristine—ABCG2—uterus—sarcoma	0.000125	0.00308	CbGeAlD
Vincristine—Infection—Thiotepa—sarcoma	0.000124	0.00185	CcSEcCtD
Vincristine—ABCC2—testis—sarcoma	0.000124	0.00307	CbGeAlD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—FOXO1—sarcoma	0.000124	0.00651	CbGpPWpGaD
Vincristine—Oedema—Dactinomycin—sarcoma	0.000124	0.00185	CcSEcCtD
Vincristine—Urethral disorder—Etoposide—sarcoma	0.000124	0.00184	CcSEcCtD
Vincristine—Infection—Dactinomycin—sarcoma	0.000123	0.00184	CcSEcCtD
Vincristine—Nervous system disorder—Thiotepa—sarcoma	0.000122	0.00183	CcSEcCtD
Vincristine—Neuropathy—Doxorubicin—sarcoma	0.000122	0.00183	CcSEcCtD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000122	0.00643	CbGpPWpGaD
Vincristine—Thrombocytopenia—Thiotepa—sarcoma	0.000122	0.00182	CcSEcCtD
Vincristine—Anaemia—Mitoxantrone—sarcoma	0.000122	0.00182	CcSEcCtD
Vincristine—Thrombocytopenia—Dactinomycin—sarcoma	0.000121	0.00181	CcSEcCtD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.00012	0.00631	CbGpPWpGaD
Vincristine—Coma—Doxorubicin—sarcoma	0.000119	0.00178	CcSEcCtD
Vincristine—Anorexia—Thiotepa—sarcoma	0.000119	0.00177	CcSEcCtD
Vincristine—Leukopenia—Mitoxantrone—sarcoma	0.000118	0.00176	CcSEcCtD
Vincristine—Anorexia—Dactinomycin—sarcoma	0.000118	0.00176	CcSEcCtD
Vincristine—Mouth ulceration—Doxorubicin—sarcoma	0.000118	0.00176	CcSEcCtD
Vincristine—ABCC2—liver—sarcoma	0.000117	0.0029	CbGeAlD
Vincristine—Cardiac disorder—Etoposide—sarcoma	0.000117	0.00175	CcSEcCtD
Vincristine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000116	0.0061	CbGpPWpGaD
Vincristine—CYP3A4—hematopoietic system—sarcoma	0.000115	0.00284	CbGeAlD
Vincristine—Angiopathy—Etoposide—sarcoma	0.000115	0.00171	CcSEcCtD
Vincristine—Convulsion—Mitoxantrone—sarcoma	0.000114	0.00171	CcSEcCtD
Vincristine—Hypertension—Mitoxantrone—sarcoma	0.000114	0.0017	CcSEcCtD
Vincristine—Hepatic failure—Epirubicin—sarcoma	0.000114	0.0017	CcSEcCtD
Vincristine—Mediastinal disorder—Etoposide—sarcoma	0.000114	0.0017	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000114	0.0017	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000113	0.00168	CcSEcCtD
Vincristine—ABCC3—lymph node—sarcoma	0.000113	0.00278	CbGeAlD
Vincristine—Myalgia—Mitoxantrone—sarcoma	0.000112	0.00168	CcSEcCtD
Vincristine—Paraesthesia—Thiotepa—sarcoma	0.000112	0.00167	CcSEcCtD
Vincristine—ABCC10—lymph node—sarcoma	0.000112	0.00277	CbGeAlD
Vincristine—Alopecia—Etoposide—sarcoma	0.000112	0.00166	CcSEcCtD
Vincristine—TUBB4B—lymph node—sarcoma	0.000111	0.00275	CbGeAlD
Vincristine—ABCC1—testis—sarcoma	0.000109	0.0027	CbGeAlD
Vincristine—Decreased appetite—Thiotepa—sarcoma	0.000109	0.00162	CcSEcCtD
Vincristine—Oedema—Mitoxantrone—sarcoma	0.000108	0.00161	CcSEcCtD
Vincristine—Anaphylactic shock—Mitoxantrone—sarcoma	0.000108	0.00161	CcSEcCtD
Vincristine—Gastrointestinal disorder—Thiotepa—sarcoma	0.000108	0.00161	CcSEcCtD
Vincristine—Decreased appetite—Dactinomycin—sarcoma	0.000108	0.00161	CcSEcCtD
Vincristine—Fatigue—Thiotepa—sarcoma	0.000108	0.0016	CcSEcCtD
Vincristine—Infection—Mitoxantrone—sarcoma	0.000107	0.0016	CcSEcCtD
Vincristine—Fatigue—Dactinomycin—sarcoma	0.000107	0.00159	CcSEcCtD
Vincristine—Pain—Thiotepa—sarcoma	0.000107	0.00159	CcSEcCtD
Vincristine—Constipation—Thiotepa—sarcoma	0.000107	0.00159	CcSEcCtD
Vincristine—Back pain—Etoposide—sarcoma	0.000106	0.00158	CcSEcCtD
Vincristine—Pain—Dactinomycin—sarcoma	0.000106	0.00158	CcSEcCtD
Vincristine—ABCG2—bone marrow—sarcoma	0.000106	0.00262	CbGeAlD
Vincristine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000106	0.00157	CcSEcCtD
Vincristine—TUBA4A—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	0.000106	0.00554	CbGpPWpGaD
Vincristine—Hepatic failure—Doxorubicin—sarcoma	0.000105	0.00157	CcSEcCtD
Vincristine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000104	0.00155	CcSEcCtD
Vincristine—ABCC1—liver—sarcoma	0.000103	0.00255	CbGeAlD
Vincristine—Anorexia—Mitoxantrone—sarcoma	0.000103	0.00153	CcSEcCtD
Vincristine—Hyponatraemia—Epirubicin—sarcoma	0.000103	0.00153	CcSEcCtD
Vincristine—NR0B1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000103	0.0054	CbGpPWpGaD
Vincristine—Pain in extremity—Epirubicin—sarcoma	0.000102	0.00153	CcSEcCtD
Vincristine—Gastrointestinal pain—Thiotepa—sarcoma	0.000102	0.00152	CcSEcCtD
Vincristine—Anaemia—Etoposide—sarcoma	0.000102	0.00151	CcSEcCtD
Vincristine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000101	0.00151	CcSEcCtD
Vincristine—Hypotension—Mitoxantrone—sarcoma	0.000101	0.0015	CcSEcCtD
Vincristine—Vertigo—Etoposide—sarcoma	9.87e-05	0.00147	CcSEcCtD
Vincristine—Abdominal pain—Thiotepa—sarcoma	9.87e-05	0.00147	CcSEcCtD
Vincristine—Body temperature increased—Thiotepa—sarcoma	9.87e-05	0.00147	CcSEcCtD
Vincristine—Leukopenia—Etoposide—sarcoma	9.84e-05	0.00147	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	9.82e-05	0.00146	CcSEcCtD
Vincristine—Abdominal pain—Dactinomycin—sarcoma	9.8e-05	0.00146	CcSEcCtD
Vincristine—Body temperature increased—Dactinomycin—sarcoma	9.8e-05	0.00146	CcSEcCtD
Vincristine—Cardiac arrest—Epirubicin—sarcoma	9.73e-05	0.00145	CcSEcCtD
Vincristine—Paraesthesia—Mitoxantrone—sarcoma	9.68e-05	0.00144	CcSEcCtD
Vincristine—Ataxia—Epirubicin—sarcoma	9.62e-05	0.00143	CcSEcCtD
Vincristine—SLC22A3—lymph node—sarcoma	9.58e-05	0.00237	CbGeAlD
Vincristine—Convulsion—Etoposide—sarcoma	9.52e-05	0.00142	CcSEcCtD
Vincristine—Dehydration—Epirubicin—sarcoma	9.51e-05	0.00142	CcSEcCtD
Vincristine—Hyponatraemia—Doxorubicin—sarcoma	9.5e-05	0.00142	CcSEcCtD
Vincristine—Hypertension—Etoposide—sarcoma	9.49e-05	0.00141	CcSEcCtD
Vincristine—ABCB1—myometrium—sarcoma	9.48e-05	0.00234	CbGeAlD
Vincristine—Pain in extremity—Doxorubicin—sarcoma	9.47e-05	0.00141	CcSEcCtD
Vincristine—Decreased appetite—Mitoxantrone—sarcoma	9.37e-05	0.0014	CcSEcCtD
Vincristine—Fatigue—Mitoxantrone—sarcoma	9.3e-05	0.00139	CcSEcCtD
Vincristine—Pain—Mitoxantrone—sarcoma	9.22e-05	0.00137	CcSEcCtD
Vincristine—Constipation—Mitoxantrone—sarcoma	9.22e-05	0.00137	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Epirubicin—sarcoma	9.21e-05	0.00137	CcSEcCtD
Vincristine—Hypersensitivity—Thiotepa—sarcoma	9.2e-05	0.00137	CcSEcCtD
Vincristine—Hypersensitivity—Dactinomycin—sarcoma	9.13e-05	0.00136	CcSEcCtD
Vincristine—ABCB1—embryo—sarcoma	9.12e-05	0.00225	CbGeAlD
Vincristine—TUBB6—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	9.05e-05	0.00476	CbGpPWpGaD
Vincristine—TUBB2B—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	9.05e-05	0.00476	CbGpPWpGaD
Vincristine—ABCG2—testis—sarcoma	9.04e-05	0.00224	CbGeAlD
Vincristine—Muscular weakness—Epirubicin—sarcoma	9.02e-05	0.00135	CcSEcCtD
Vincristine—Cardiac arrest—Doxorubicin—sarcoma	9e-05	0.00134	CcSEcCtD
Vincristine—ABCC2—lymph node—sarcoma	8.99e-05	0.00222	CbGeAlD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—CREB1—sarcoma	8.99e-05	0.00472	CbGpPWpGaD
Vincristine—ABCG2—HIF-2-alpha transcription factor network—KDR—sarcoma	8.97e-05	0.00471	CbGpPWpGaD
Vincristine—TUBB—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	8.97e-05	0.00471	CbGpPWpGaD
Vincristine—Anaphylactic shock—Etoposide—sarcoma	8.97e-05	0.00134	CcSEcCtD
Vincristine—Asthenia—Thiotepa—sarcoma	8.96e-05	0.00134	CcSEcCtD
Vincristine—ABCC1—S1P1 pathway—VEGFA—sarcoma	8.95e-05	0.0047	CbGpPWpGaD
Vincristine—Infection—Etoposide—sarcoma	8.91e-05	0.00133	CcSEcCtD
Vincristine—Ataxia—Doxorubicin—sarcoma	8.9e-05	0.00133	CcSEcCtD
Vincristine—Asthenia—Dactinomycin—sarcoma	8.89e-05	0.00133	CcSEcCtD
Vincristine—Gastrointestinal pain—Mitoxantrone—sarcoma	8.82e-05	0.00131	CcSEcCtD
Vincristine—Dehydration—Doxorubicin—sarcoma	8.8e-05	0.00131	CcSEcCtD
Vincristine—Thrombocytopenia—Etoposide—sarcoma	8.78e-05	0.00131	CcSEcCtD
Vincristine—TUBB3—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	8.74e-05	0.00459	CbGpPWpGaD
Vincristine—Hyperhidrosis—Etoposide—sarcoma	8.67e-05	0.00129	CcSEcCtD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—CXCR4—sarcoma	8.64e-05	0.00454	CbGpPWpGaD
Vincristine—ABCB1—seminal vesicle—sarcoma	8.56e-05	0.00212	CbGeAlD
Vincristine—ABCG2—liver—sarcoma	8.55e-05	0.00211	CbGeAlD
Vincristine—Anorexia—Etoposide—sarcoma	8.55e-05	0.00127	CcSEcCtD
Vincristine—Diarrhoea—Thiotepa—sarcoma	8.54e-05	0.00127	CcSEcCtD
Vincristine—Body temperature increased—Mitoxantrone—sarcoma	8.52e-05	0.00127	CcSEcCtD
Vincristine—Abdominal pain—Mitoxantrone—sarcoma	8.52e-05	0.00127	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Doxorubicin—sarcoma	8.52e-05	0.00127	CcSEcCtD
Vincristine—Diarrhoea—Dactinomycin—sarcoma	8.48e-05	0.00126	CcSEcCtD
Vincristine—TUBB2A—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	8.47e-05	0.00445	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TEK—sarcoma	8.44e-05	0.00443	CbGpPWpGaD
Vincristine—Pancytopenia—Epirubicin—sarcoma	8.4e-05	0.00125	CcSEcCtD
Vincristine—Hypotension—Etoposide—sarcoma	8.38e-05	0.00125	CcSEcCtD
Vincristine—Muscular weakness—Doxorubicin—sarcoma	8.35e-05	0.00124	CcSEcCtD
Vincristine—TUBB1—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	8.28e-05	0.00435	CbGpPWpGaD
Vincristine—Neutropenia—Epirubicin—sarcoma	8.27e-05	0.00123	CcSEcCtD
Vincristine—Dysuria—Epirubicin—sarcoma	8.27e-05	0.00123	CcSEcCtD
Vincristine—Dizziness—Thiotepa—sarcoma	8.26e-05	0.00123	CcSEcCtD
Vincristine—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	8.16e-05	0.00429	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—STAG1—sarcoma	8.15e-05	0.00428	CbGpPWpGaD
Vincristine—ABCB1—hematopoietic system—sarcoma	8.14e-05	0.00201	CbGeAlD
Vincristine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	8.08e-05	0.00425	CbGpPWpGaD
Vincristine—Photosensitivity reaction—Epirubicin—sarcoma	8.07e-05	0.0012	CcSEcCtD
Vincristine—Paraesthesia—Etoposide—sarcoma	8.05e-05	0.0012	CcSEcCtD
Vincristine—Weight decreased—Epirubicin—sarcoma	8e-05	0.00119	CcSEcCtD
Vincristine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	7.96e-05	0.00418	CbGpPWpGaD
Vincristine—Hypersensitivity—Mitoxantrone—sarcoma	7.94e-05	0.00118	CcSEcCtD
Vincristine—Vomiting—Thiotepa—sarcoma	7.94e-05	0.00118	CcSEcCtD
Vincristine—CYP3A5—liver—sarcoma	7.94e-05	0.00196	CbGeAlD
Vincristine—Pneumonia—Epirubicin—sarcoma	7.93e-05	0.00118	CcSEcCtD
Vincristine—ABCC1—lymph node—sarcoma	7.92e-05	0.00196	CbGeAlD
Vincristine—Vomiting—Dactinomycin—sarcoma	7.88e-05	0.00117	CcSEcCtD
Vincristine—NR0B1—Gene Expression—FUS—sarcoma	7.88e-05	0.00414	CbGpPWpGaD
Vincristine—Rash—Thiotepa—sarcoma	7.87e-05	0.00117	CcSEcCtD
Vincristine—Dermatitis—Thiotepa—sarcoma	7.87e-05	0.00117	CcSEcCtD
Vincristine—Headache—Thiotepa—sarcoma	7.82e-05	0.00117	CcSEcCtD
Vincristine—Rash—Dactinomycin—sarcoma	7.81e-05	0.00116	CcSEcCtD
Vincristine—Decreased appetite—Etoposide—sarcoma	7.8e-05	0.00116	CcSEcCtD
Vincristine—Pancytopenia—Doxorubicin—sarcoma	7.77e-05	0.00116	CcSEcCtD
Vincristine—Gastrointestinal disorder—Etoposide—sarcoma	7.74e-05	0.00115	CcSEcCtD
Vincristine—Asthenia—Mitoxantrone—sarcoma	7.74e-05	0.00115	CcSEcCtD
Vincristine—Fatigue—Etoposide—sarcoma	7.73e-05	0.00115	CcSEcCtD
Vincristine—Neuropathy peripheral—Epirubicin—sarcoma	7.73e-05	0.00115	CcSEcCtD
Vincristine—TUBA4A—Hemostasis—ANGPT2—sarcoma	7.72e-05	0.00406	CbGpPWpGaD
Vincristine—Stomatitis—Epirubicin—sarcoma	7.68e-05	0.00115	CcSEcCtD
Vincristine—Pain—Etoposide—sarcoma	7.67e-05	0.00114	CcSEcCtD
Vincristine—Constipation—Etoposide—sarcoma	7.67e-05	0.00114	CcSEcCtD
Vincristine—Dysuria—Doxorubicin—sarcoma	7.65e-05	0.00114	CcSEcCtD
Vincristine—Neutropenia—Doxorubicin—sarcoma	7.65e-05	0.00114	CcSEcCtD
Vincristine—Sweating—Epirubicin—sarcoma	7.56e-05	0.00113	CcSEcCtD
Vincristine—Photosensitivity reaction—Doxorubicin—sarcoma	7.47e-05	0.00111	CcSEcCtD
Vincristine—TUBB4A—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	7.44e-05	0.00391	CbGpPWpGaD
Vincristine—Nausea—Thiotepa—sarcoma	7.42e-05	0.00111	CcSEcCtD
Vincristine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—sarcoma	7.42e-05	0.0039	CbGpPWpGaD
Vincristine—Weight decreased—Doxorubicin—sarcoma	7.4e-05	0.0011	CcSEcCtD
Vincristine—Diarrhoea—Mitoxantrone—sarcoma	7.38e-05	0.0011	CcSEcCtD
Vincristine—Nausea—Dactinomycin—sarcoma	7.36e-05	0.0011	CcSEcCtD
Vincristine—Pneumonia—Doxorubicin—sarcoma	7.34e-05	0.00109	CcSEcCtD
Vincristine—Gastrointestinal pain—Etoposide—sarcoma	7.33e-05	0.00109	CcSEcCtD
Vincristine—TUBA4A—Cell Cycle—STAG1—sarcoma	7.28e-05	0.00383	CbGpPWpGaD
Vincristine—Neuropathy peripheral—Doxorubicin—sarcoma	7.15e-05	0.00107	CcSEcCtD
Vincristine—Stomatitis—Doxorubicin—sarcoma	7.11e-05	0.00106	CcSEcCtD
Vincristine—Abdominal pain—Etoposide—sarcoma	7.09e-05	0.00106	CcSEcCtD
Vincristine—Body temperature increased—Etoposide—sarcoma	7.09e-05	0.00106	CcSEcCtD
Vincristine—Hypoaesthesia—Epirubicin—sarcoma	7.04e-05	0.00105	CcSEcCtD
Vincristine—Sweating—Doxorubicin—sarcoma	6.99e-05	0.00104	CcSEcCtD
Vincristine—Urinary tract disorder—Epirubicin—sarcoma	6.99e-05	0.00104	CcSEcCtD
Vincristine—Connective tissue disorder—Epirubicin—sarcoma	6.95e-05	0.00104	CcSEcCtD
Vincristine—Urethral disorder—Epirubicin—sarcoma	6.94e-05	0.00103	CcSEcCtD
Vincristine—TUBB—Cell Cycle, Mitotic—STAG1—sarcoma	6.93e-05	0.00364	CbGpPWpGaD
Vincristine—TUBA4A—Platelet degranulation—VEGFA—sarcoma	6.88e-05	0.00362	CbGpPWpGaD
Vincristine—Vomiting—Mitoxantrone—sarcoma	6.86e-05	0.00102	CcSEcCtD
Vincristine—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	6.8e-05	0.00357	CbGpPWpGaD
Vincristine—Rash—Mitoxantrone—sarcoma	6.8e-05	0.00101	CcSEcCtD
Vincristine—Dermatitis—Mitoxantrone—sarcoma	6.79e-05	0.00101	CcSEcCtD
Vincristine—Headache—Mitoxantrone—sarcoma	6.76e-05	0.00101	CcSEcCtD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	6.62e-05	0.00348	CbGpPWpGaD
Vincristine—Hypersensitivity—Etoposide—sarcoma	6.61e-05	0.000985	CcSEcCtD
Vincristine—Cardiac disorder—Epirubicin—sarcoma	6.57e-05	0.000979	CcSEcCtD
Vincristine—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	6.56e-05	0.00345	CbGpPWpGaD
Vincristine—ABCG2—lymph node—sarcoma	6.56e-05	0.00162	CbGeAlD
Vincristine—Hypoaesthesia—Doxorubicin—sarcoma	6.51e-05	0.000971	CcSEcCtD
Vincristine—Urinary tract disorder—Doxorubicin—sarcoma	6.47e-05	0.000964	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—JUN—sarcoma	6.46e-05	0.0034	CbGpPWpGaD
Vincristine—Asthenia—Etoposide—sarcoma	6.44e-05	0.000959	CcSEcCtD
Vincristine—Connective tissue disorder—Doxorubicin—sarcoma	6.43e-05	0.000959	CcSEcCtD
Vincristine—Angiopathy—Epirubicin—sarcoma	6.42e-05	0.000957	CcSEcCtD
Vincristine—Urethral disorder—Doxorubicin—sarcoma	6.42e-05	0.000957	CcSEcCtD
Vincristine—Nausea—Mitoxantrone—sarcoma	6.4e-05	0.000955	CcSEcCtD
Vincristine—Mediastinal disorder—Epirubicin—sarcoma	6.38e-05	0.000951	CcSEcCtD
Vincristine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	6.28e-05	0.0033	CbGpPWpGaD
Vincristine—Alopecia—Epirubicin—sarcoma	6.25e-05	0.000932	CcSEcCtD
Vincristine—TUBA4A—Cell Cycle—NPM1—sarcoma	6.25e-05	0.00328	CbGpPWpGaD
Vincristine—Mental disorder—Epirubicin—sarcoma	6.2e-05	0.000924	CcSEcCtD
Vincristine—TUBA4A—Hemostasis—VEGFC—sarcoma	6.19e-05	0.00325	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—STAG1—sarcoma	6.19e-05	0.00325	CbGpPWpGaD
Vincristine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	6.17e-05	0.00324	CbGpPWpGaD
Vincristine—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	6.16e-05	0.00323	CbGpPWpGaD
Vincristine—ABCB1—uterus—sarcoma	6.15e-05	0.00152	CbGeAlD
Vincristine—Diarrhoea—Etoposide—sarcoma	6.14e-05	0.000915	CcSEcCtD
Vincristine—Cardiac disorder—Doxorubicin—sarcoma	6.08e-05	0.000906	CcSEcCtD
Vincristine—Back pain—Epirubicin—sarcoma	5.96e-05	0.000888	CcSEcCtD
Vincristine—CYP3A4—liver—sarcoma	5.96e-05	0.00147	CbGeAlD
Vincristine—Angiopathy—Doxorubicin—sarcoma	5.94e-05	0.000886	CcSEcCtD
Vincristine—Dizziness—Etoposide—sarcoma	5.93e-05	0.000884	CcSEcCtD
Vincristine—Mediastinal disorder—Doxorubicin—sarcoma	5.9e-05	0.00088	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—SRC—sarcoma	5.8e-05	0.00305	CbGpPWpGaD
Vincristine—Alopecia—Doxorubicin—sarcoma	5.79e-05	0.000863	CcSEcCtD
Vincristine—TUBB4A—Cell Cycle, Mitotic—STAG1—sarcoma	5.74e-05	0.00302	CbGpPWpGaD
Vincristine—Mental disorder—Doxorubicin—sarcoma	5.74e-05	0.000855	CcSEcCtD
Vincristine—ABCB1—lymphoid tissue—sarcoma	5.73e-05	0.00142	CbGeAlD
Vincristine—Vomiting—Etoposide—sarcoma	5.7e-05	0.00085	CcSEcCtD
Vincristine—Anaemia—Epirubicin—sarcoma	5.69e-05	0.000849	CcSEcCtD
Vincristine—Agitation—Epirubicin—sarcoma	5.66e-05	0.000844	CcSEcCtD
Vincristine—Rash—Etoposide—sarcoma	5.66e-05	0.000843	CcSEcCtD
Vincristine—Dermatitis—Etoposide—sarcoma	5.65e-05	0.000842	CcSEcCtD
Vincristine—Headache—Etoposide—sarcoma	5.62e-05	0.000838	CcSEcCtD
Vincristine—ABCC3—Fluoropyrimidine Activity—TP53—sarcoma	5.55e-05	0.00292	CbGpPWpGaD
Vincristine—Vertigo—Epirubicin—sarcoma	5.53e-05	0.000825	CcSEcCtD
Vincristine—Leukopenia—Epirubicin—sarcoma	5.51e-05	0.000822	CcSEcCtD
Vincristine—Back pain—Doxorubicin—sarcoma	5.51e-05	0.000822	CcSEcCtD
Vincristine—Convulsion—Epirubicin—sarcoma	5.34e-05	0.000796	CcSEcCtD
Vincristine—Nausea—Etoposide—sarcoma	5.33e-05	0.000794	CcSEcCtD
Vincristine—Hypertension—Epirubicin—sarcoma	5.32e-05	0.000793	CcSEcCtD
Vincristine—TUBB—Cell Cycle—NPM1—sarcoma	5.31e-05	0.00279	CbGpPWpGaD
Vincristine—Anaemia—Doxorubicin—sarcoma	5.27e-05	0.000785	CcSEcCtD
Vincristine—TUBB4B—Cell Cycle, Mitotic—STAG1—sarcoma	5.25e-05	0.00276	CbGpPWpGaD
Vincristine—Myalgia—Epirubicin—sarcoma	5.24e-05	0.000782	CcSEcCtD
Vincristine—Agitation—Doxorubicin—sarcoma	5.24e-05	0.000781	CcSEcCtD
Vincristine—ABCB1—bone marrow—sarcoma	5.22e-05	0.00129	CbGeAlD
Vincristine—TUBB4A—Cell Cycle—STAG1—sarcoma	5.13e-05	0.0027	CbGpPWpGaD
Vincristine—Vertigo—Doxorubicin—sarcoma	5.12e-05	0.000763	CcSEcCtD
Vincristine—Leukopenia—Doxorubicin—sarcoma	5.1e-05	0.000761	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—EGFR—sarcoma	5.08e-05	0.00267	CbGpPWpGaD
Vincristine—Oedema—Epirubicin—sarcoma	5.03e-05	0.00075	CcSEcCtD
Vincristine—Anaphylactic shock—Epirubicin—sarcoma	5.03e-05	0.00075	CcSEcCtD
Vincristine—Infection—Epirubicin—sarcoma	4.99e-05	0.000745	CcSEcCtD
Vincristine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—sarcoma	4.94e-05	0.0026	CbGpPWpGaD
Vincristine—Convulsion—Doxorubicin—sarcoma	4.94e-05	0.000736	CcSEcCtD
Vincristine—Nervous system disorder—Epirubicin—sarcoma	4.93e-05	0.000735	CcSEcCtD
Vincristine—Thrombocytopenia—Epirubicin—sarcoma	4.92e-05	0.000734	CcSEcCtD
Vincristine—Hypertension—Doxorubicin—sarcoma	4.92e-05	0.000734	CcSEcCtD
Vincristine—TUBA4A—Hemostasis—PLCG1—sarcoma	4.87e-05	0.00256	CbGpPWpGaD
Vincristine—Hyperhidrosis—Epirubicin—sarcoma	4.86e-05	0.000725	CcSEcCtD
Vincristine—Myalgia—Doxorubicin—sarcoma	4.85e-05	0.000723	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—KRAS—sarcoma	4.8e-05	0.00252	CbGpPWpGaD
Vincristine—Anorexia—Epirubicin—sarcoma	4.79e-05	0.000714	CcSEcCtD
Vincristine—Hypotension—Epirubicin—sarcoma	4.7e-05	0.0007	CcSEcCtD
Vincristine—TUBB4B—Cell Cycle—STAG1—sarcoma	4.69e-05	0.00247	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	4.67e-05	0.00245	CbGpPWpGaD
Vincristine—Anaphylactic shock—Doxorubicin—sarcoma	4.65e-05	0.000694	CcSEcCtD
Vincristine—Oedema—Doxorubicin—sarcoma	4.65e-05	0.000694	CcSEcCtD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—CREB1—sarcoma	4.63e-05	0.00243	CbGpPWpGaD
Vincristine—Infection—Doxorubicin—sarcoma	4.62e-05	0.000689	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Epirubicin—sarcoma	4.58e-05	0.000683	CcSEcCtD
Vincristine—Nervous system disorder—Doxorubicin—sarcoma	4.56e-05	0.00068	CcSEcCtD
Vincristine—Thrombocytopenia—Doxorubicin—sarcoma	4.55e-05	0.000679	CcSEcCtD
Vincristine—Insomnia—Epirubicin—sarcoma	4.55e-05	0.000678	CcSEcCtD
Vincristine—Paraesthesia—Epirubicin—sarcoma	4.51e-05	0.000673	CcSEcCtD
Vincristine—Hyperhidrosis—Doxorubicin—sarcoma	4.5e-05	0.00067	CcSEcCtD
Vincristine—ABCB1—testis—sarcoma	4.46e-05	0.0011	CbGeAlD
Vincristine—Anorexia—Doxorubicin—sarcoma	4.43e-05	0.000661	CcSEcCtD
Vincristine—TUBB4A—Cell Cycle—NPM1—sarcoma	4.4e-05	0.00231	CbGpPWpGaD
Vincristine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	4.37e-05	0.0023	CbGpPWpGaD
Vincristine—Decreased appetite—Epirubicin—sarcoma	4.37e-05	0.000652	CcSEcCtD
Vincristine—Hypotension—Doxorubicin—sarcoma	4.35e-05	0.000648	CcSEcCtD
Vincristine—Gastrointestinal disorder—Epirubicin—sarcoma	4.34e-05	0.000647	CcSEcCtD
Vincristine—Fatigue—Epirubicin—sarcoma	4.33e-05	0.000646	CcSEcCtD
Vincristine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	4.3e-05	0.00226	CbGpPWpGaD
Vincristine—Constipation—Epirubicin—sarcoma	4.3e-05	0.000641	CcSEcCtD
Vincristine—Pain—Epirubicin—sarcoma	4.3e-05	0.000641	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Doxorubicin—sarcoma	4.24e-05	0.000632	CcSEcCtD
Vincristine—ABCB1—liver—sarcoma	4.22e-05	0.00104	CbGeAlD
Vincristine—Insomnia—Doxorubicin—sarcoma	4.21e-05	0.000627	CcSEcCtD
Vincristine—Paraesthesia—Doxorubicin—sarcoma	4.18e-05	0.000623	CcSEcCtD
Vincristine—Gastrointestinal pain—Epirubicin—sarcoma	4.11e-05	0.000613	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—HRAS—sarcoma	4.08e-05	0.00214	CbGpPWpGaD
Vincristine—Decreased appetite—Doxorubicin—sarcoma	4.04e-05	0.000603	CcSEcCtD
Vincristine—TUBB4B—Cell Cycle—NPM1—sarcoma	4.03e-05	0.00212	CbGpPWpGaD
Vincristine—Gastrointestinal disorder—Doxorubicin—sarcoma	4.02e-05	0.000599	CcSEcCtD
Vincristine—Fatigue—Doxorubicin—sarcoma	4.01e-05	0.000598	CcSEcCtD
Vincristine—Constipation—Doxorubicin—sarcoma	3.98e-05	0.000593	CcSEcCtD
Vincristine—Pain—Doxorubicin—sarcoma	3.98e-05	0.000593	CcSEcCtD
Vincristine—Abdominal pain—Epirubicin—sarcoma	3.97e-05	0.000593	CcSEcCtD
Vincristine—Body temperature increased—Epirubicin—sarcoma	3.97e-05	0.000593	CcSEcCtD
Vincristine—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	3.83e-05	0.00201	CbGpPWpGaD
Vincristine—Gastrointestinal pain—Doxorubicin—sarcoma	3.8e-05	0.000567	CcSEcCtD
Vincristine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	3.79e-05	0.00199	CbGpPWpGaD
Vincristine—Hypersensitivity—Epirubicin—sarcoma	3.7e-05	0.000552	CcSEcCtD
Vincristine—Abdominal pain—Doxorubicin—sarcoma	3.68e-05	0.000548	CcSEcCtD
Vincristine—Body temperature increased—Doxorubicin—sarcoma	3.68e-05	0.000548	CcSEcCtD
Vincristine—Asthenia—Epirubicin—sarcoma	3.61e-05	0.000538	CcSEcCtD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—IL2—sarcoma	3.59e-05	0.00189	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TLE1—sarcoma	3.59e-05	0.00189	CbGpPWpGaD
Vincristine—Diarrhoea—Epirubicin—sarcoma	3.44e-05	0.000513	CcSEcCtD
Vincristine—Hypersensitivity—Doxorubicin—sarcoma	3.43e-05	0.000511	CcSEcCtD
Vincristine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	3.4e-05	0.00178	CbGpPWpGaD
Vincristine—Asthenia—Doxorubicin—sarcoma	3.34e-05	0.000498	CcSEcCtD
Vincristine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	3.34e-05	0.00175	CbGpPWpGaD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	3.33e-05	0.00175	CbGpPWpGaD
Vincristine—Dizziness—Epirubicin—sarcoma	3.32e-05	0.000496	CcSEcCtD
Vincristine—ABCB1—lymph node—sarcoma	3.23e-05	0.000799	CbGeAlD
Vincristine—Vomiting—Epirubicin—sarcoma	3.2e-05	0.000477	CcSEcCtD
Vincristine—Diarrhoea—Doxorubicin—sarcoma	3.18e-05	0.000475	CcSEcCtD
Vincristine—Rash—Epirubicin—sarcoma	3.17e-05	0.000473	CcSEcCtD
Vincristine—Dermatitis—Epirubicin—sarcoma	3.17e-05	0.000472	CcSEcCtD
Vincristine—Headache—Epirubicin—sarcoma	3.15e-05	0.00047	CcSEcCtD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—SRC—sarcoma	3.14e-05	0.00165	CbGpPWpGaD
Vincristine—Dizziness—Doxorubicin—sarcoma	3.08e-05	0.000459	CcSEcCtD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—sarcoma	3.05e-05	0.0016	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—VEGFC—sarcoma	3.03e-05	0.00159	CbGpPWpGaD
Vincristine—Nausea—Epirubicin—sarcoma	2.99e-05	0.000445	CcSEcCtD
Vincristine—Vomiting—Doxorubicin—sarcoma	2.96e-05	0.000441	CcSEcCtD
Vincristine—ABCB1—Allograft Rejection—PDGFRA—sarcoma	2.94e-05	0.00154	CbGpPWpGaD
Vincristine—Rash—Doxorubicin—sarcoma	2.93e-05	0.000437	CcSEcCtD
Vincristine—Dermatitis—Doxorubicin—sarcoma	2.93e-05	0.000437	CcSEcCtD
Vincristine—Headache—Doxorubicin—sarcoma	2.91e-05	0.000434	CcSEcCtD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	2.91e-05	0.00153	CbGpPWpGaD
Vincristine—Nausea—Doxorubicin—sarcoma	2.76e-05	0.000412	CcSEcCtD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	2.73e-05	0.00143	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	2.5e-05	0.00131	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—FLT1—sarcoma	2.42e-05	0.00127	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PLCG1—sarcoma	2.38e-05	0.00125	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CXCR4—sarcoma	2.29e-05	0.0012	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—ATF1—sarcoma	2.26e-05	0.00119	CbGpPWpGaD
Vincristine—NR0B1—Generic Transcription Pathway—MYC—sarcoma	2.13e-05	0.00112	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MDM2—sarcoma	1.96e-05	0.00103	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CCND1—sarcoma	1.91e-05	0.001	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—IL2—sarcoma	1.85e-05	0.000973	CbGpPWpGaD
Vincristine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	1.84e-05	0.000965	CbGpPWpGaD
Vincristine—TUBA4A—Metabolism of proteins—MMP2—sarcoma	1.83e-05	0.000964	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	1.8e-05	0.000946	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IGF1R—sarcoma	1.77e-05	0.000932	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CCND1—sarcoma	1.7e-05	0.000895	CbGpPWpGaD
Vincristine—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	1.7e-05	0.000895	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—FOXO1—sarcoma	1.69e-05	0.000888	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PDGFRB—sarcoma	1.69e-05	0.000886	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MDM2—sarcoma	1.66e-05	0.000874	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PDGFRA—sarcoma	1.66e-05	0.000872	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CCND1—sarcoma	1.62e-05	0.000851	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—SRC—sarcoma	1.62e-05	0.000849	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—IL2—sarcoma	1.6e-05	0.000842	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—MMP2—sarcoma	1.57e-05	0.000827	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—MMP2—sarcoma	1.57e-05	0.000827	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—VEGFA—sarcoma	1.57e-05	0.000827	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	1.57e-05	0.000826	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—NRAS—sarcoma	1.55e-05	0.000817	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—MYC—sarcoma	1.53e-05	0.000803	CbGpPWpGaD
Vincristine—TUBB3—Metabolism of proteins—MMP2—sarcoma	1.52e-05	0.000799	CbGpPWpGaD
Vincristine—TUBB2A—Metabolism of proteins—MMP2—sarcoma	1.47e-05	0.000773	CbGpPWpGaD
Vincristine—ABCC1—Disease—TLE1—sarcoma	1.46e-05	0.000769	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	1.45e-05	0.000761	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CCND1—sarcoma	1.45e-05	0.000761	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—MMP2—sarcoma	1.44e-05	0.000756	CbGpPWpGaD
Vincristine—TUBA4A—Metabolism of proteins—CTNNB1—sarcoma	1.41e-05	0.000739	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—KDR—sarcoma	1.4e-05	0.000734	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MDM2—sarcoma	1.38e-05	0.000724	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MYC—sarcoma	1.37e-05	0.000718	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—VEGFA—sarcoma	1.36e-05	0.000715	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CCND1—sarcoma	1.34e-05	0.000705	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—KRAS—sarcoma	1.34e-05	0.000703	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ENO2—sarcoma	1.33e-05	0.000698	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—HBA1—sarcoma	1.32e-05	0.000694	CbGpPWpGaD
Vincristine—ABCC1—Disease—NPM1—sarcoma	1.32e-05	0.000693	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—MYC—sarcoma	1.3e-05	0.000683	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—MMP2—sarcoma	1.29e-05	0.000679	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—KIT—sarcoma	1.29e-05	0.000676	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ENO2—sarcoma	1.27e-05	0.00067	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—HBA1—sarcoma	1.27e-05	0.000665	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MDM2—sarcoma	1.26e-05	0.000662	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CCND1—sarcoma	1.23e-05	0.000645	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CREB1—sarcoma	1.23e-05	0.000644	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ENO2—sarcoma	1.22e-05	0.000642	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—HBA1—sarcoma	1.21e-05	0.000638	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—CTNNB1—sarcoma	1.21e-05	0.000634	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—CTNNB1—sarcoma	1.21e-05	0.000634	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CCND1—sarcoma	1.2e-05	0.000631	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TP53—sarcoma	1.19e-05	0.000625	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—MMP2—sarcoma	1.18e-05	0.000621	CbGpPWpGaD
Vincristine—TUBB3—Metabolism of proteins—CTNNB1—sarcoma	1.17e-05	0.000612	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MYC—sarcoma	1.16e-05	0.000611	CbGpPWpGaD
Vincristine—ABCC1—Disease—ENO2—sarcoma	1.14e-05	0.000601	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—HRAS—sarcoma	1.14e-05	0.000598	CbGpPWpGaD
Vincristine—TUBB2A—Metabolism of proteins—CTNNB1—sarcoma	1.13e-05	0.000593	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PLCG1—sarcoma	1.13e-05	0.000593	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TP53—sarcoma	1.12e-05	0.00059	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—CTNNB1—sarcoma	1.1e-05	0.00058	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CCND1—sarcoma	1.1e-05	0.000577	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PLCG1—sarcoma	1.08e-05	0.000568	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MYC—sarcoma	1.08e-05	0.000566	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	1.07e-05	0.000562	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PLCG1—sarcoma	1.04e-05	0.000545	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—MYC—sarcoma	1.02e-05	0.000538	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MDM2—sarcoma	1.01e-05	0.000533	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—CTNNB1—sarcoma	9.91e-06	0.000521	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MYC—sarcoma	9.85e-06	0.000517	CbGpPWpGaD
Vincristine—ABCC1—Disease—PLCG1—sarcoma	9.7e-06	0.00051	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MYC—sarcoma	9.63e-06	0.000506	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ENO2—sarcoma	9.57e-06	0.000503	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TP53—sarcoma	9.54e-06	0.000501	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—HBA1—sarcoma	9.51e-06	0.0005	CbGpPWpGaD
Vincristine—ABCC1—Disease—CXCR4—sarcoma	9.32e-06	0.00049	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—CTNNB1—sarcoma	9.06e-06	0.000476	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL2—sarcoma	9.06e-06	0.000476	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	8.85e-06	0.000465	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CCND1—sarcoma	8.83e-06	0.000464	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—JUN—sarcoma	8.81e-06	0.000463	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MYC—sarcoma	8.81e-06	0.000463	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CTNNB1—sarcoma	8.74e-06	0.000459	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ENO2—sarcoma	8.42e-06	0.000443	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—HBA1—sarcoma	8.37e-06	0.00044	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ENO2—sarcoma	8.35e-06	0.000439	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—HBA1—sarcoma	8.3e-06	0.000436	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PLCG1—sarcoma	8.12e-06	0.000427	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TP53—sarcoma	7.91e-06	0.000415	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—SRC—sarcoma	7.9e-06	0.000415	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	7.71e-06	0.000405	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—VEGFA—sarcoma	7.7e-06	0.000404	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	7.69e-06	0.000404	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	7.63e-06	0.000401	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—NRAS—sarcoma	7.6e-06	0.0004	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TP53—sarcoma	7.23e-06	0.00038	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PLCG1—sarcoma	7.15e-06	0.000376	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PLCG1—sarcoma	7.09e-06	0.000372	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MYC—sarcoma	7.08e-06	0.000372	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—EGFR—sarcoma	6.93e-06	0.000364	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	6.9e-06	0.000362	CbGpPWpGaD
Vincristine—ABCC1—Disease—FOXO1—sarcoma	6.88e-06	0.000362	CbGpPWpGaD
Vincristine—ABCC1—Disease—PDGFRB—sarcoma	6.87e-06	0.000361	CbGpPWpGaD
Vincristine—ABCC1—Disease—PDGFRA—sarcoma	6.76e-06	0.000355	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	6.72e-06	0.000353	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—KRAS—sarcoma	6.54e-06	0.000344	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	6.18e-06	0.000325	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	6.05e-06	0.000318	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ENO2—sarcoma	6.04e-06	0.000317	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—HBA1—sarcoma	6e-06	0.000315	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TP53—sarcoma	5.82e-06	0.000306	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	5.71e-06	0.0003	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—HRAS—sarcoma	5.56e-06	0.000292	CbGpPWpGaD
Vincristine—ABCC1—Disease—KIT—sarcoma	5.24e-06	0.000276	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PLCG1—sarcoma	5.12e-06	0.000269	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	5.08e-06	0.000267	CbGpPWpGaD
Vincristine—ABCC1—Disease—CREB1—sarcoma	4.99e-06	0.000262	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ENO2—sarcoma	4.55e-06	0.000239	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—HBA1—sarcoma	4.53e-06	0.000238	CbGpPWpGaD
Vincristine—ABCC1—Disease—MDM2—sarcoma	4.13e-06	0.000217	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PLCG1—sarcoma	3.86e-06	0.000203	CbGpPWpGaD
Vincristine—ABCC1—Disease—CTNNB1—sarcoma	3.56e-06	0.000187	CbGpPWpGaD
Vincristine—ABCC1—Disease—SRC—sarcoma	3.22e-06	0.000169	CbGpPWpGaD
Vincristine—ABCC1—Disease—NRAS—sarcoma	3.1e-06	0.000163	CbGpPWpGaD
Vincristine—ABCC1—Disease—MYC—sarcoma	2.89e-06	0.000152	CbGpPWpGaD
Vincristine—ABCC1—Disease—EGFR—sarcoma	2.82e-06	0.000148	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ENO2—sarcoma	2.81e-06	0.000147	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—HBA1—sarcoma	2.79e-06	0.000147	CbGpPWpGaD
Vincristine—ABCC1—Disease—KRAS—sarcoma	2.67e-06	0.00014	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PLCG1—sarcoma	2.38e-06	0.000125	CbGpPWpGaD
Vincristine—ABCC1—Disease—HRAS—sarcoma	2.27e-06	0.000119	CbGpPWpGaD
